Needham Maintains Buy on Astrana Health, Raises Price Target to $45
Benzinga Newsdesk 11 hours ago
Analyst RatingsNewsPrice Target
Needham analyst Matthew Shea maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $41 to $45.
Needham analyst Matthew Shea maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $41 to $45.